D.A. Davidson & Co. Harrow Health, Inc. Transaction History
D.A. Davidson & Co.
- $12 Billion
- Q3 2024
A detailed history of D.A. Davidson & Co. transactions in Harrow Health, Inc. stock. As of the latest transaction made, D.A. Davidson & Co. holds 61,941 shares of HROW stock, worth $2.27 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
61,941
Previous 64,212
3.54%
Holding current value
$2.27 Million
Previous $1.34 Million
107.61%
% of portfolio
0.02%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding HROW
# of Institutions
177Shares Held
21.4MCall Options Held
845KPut Options Held
717K-
Opaleye Management Inc. Boston, MA3.99MShares$146 Million32.75% of portfolio
-
Private Capital Management, LLC Naples, FL2.16MShares$79.3 Million11.41% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$78.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$68.4 Million0.0% of portfolio
-
State Street Corp Boston, MA731KShares$26.8 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $992M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...